These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Imaging of NASH].
    Author: Tanimoto A, Tomita K.
    Journal: Nihon Rinsho; 2006 Jun; 64(6):1127-32. PubMed ID: 16768120.
    Abstract:
    Nonalcoholic steatohepatitis (NASH) is the most serious form of nonalcoholic fatty liver disease (NAFLD). Although imaging studies identify hepatic steatosis when the amount of fat in the liver is significant, differences between NASH and nonprogressive NAFLD were not apparent with any imaging modalities. Ultimately a liver biopsy is needed to diagnose NASH. Because NASH is a progressive fibrotic disease, patients with NASH and cirrhosis may progress to hepatocellular carcinoma(HCC). Regular screening based on tumor markers and imaging modalities is needed to detect HCC, in patients with NASH and cirrhosis.
    [Abstract] [Full Text] [Related] [New Search]